Gland Pharma, and other pharma stocks surge up to 14% as Trump spares sector from new tariffs

Shares of Indian pharma companies with substantial exposure to the U.S., such as Gland Pharma, Aurobindo Pharma, Dr. Reddy's Laboratories, and Sun Pharma, surged by as much as 14% on Thursday, April 3, after U.S. President Donald Trump chose not to impose new reciprocal tariffs on the sector.